InterCure (NASDAQ:INCR) Stock Price Down 3.4% – Time to Sell?

InterCure Ltd. (NASDAQ:INCR) fell 3.4% on Monday . The company traded as low as $1.43 and last traded at $1.44. 37,166 shares changed hands during mid-day trading, a decline of 6% from the average session volume of 39,383 shares. The stock had previously closed at $1.49.

InterCure Stock Down 3.4 %

The stock has a fifty day moving average price of $1.63 and a two-hundred day moving average price of $1.64. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.78 and a quick ratio of 1.15.

Institutional Trading of InterCure

A number of institutional investors and hedge funds have recently modified their holdings of the business. Moore Capital Management LP bought a new stake in shares of InterCure during the 4th quarter valued at about $156,000. Virtu Financial LLC acquired a new stake in shares of InterCure during the 3rd quarter worth approximately $43,000. Finally, Jane Street Group LLC acquired a new position in InterCure during the 3rd quarter valued at approximately $49,000. 8.34% of the stock is owned by institutional investors and hedge funds.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.